HomeELDN • NASDAQ
add
Eledon Pharmaceuticals Inc
Previous close
$2.02
Day range
$1.99 - $2.20
Year range
$1.07 - $2.95
Market cap
53.60M USD
Avg Volume
130.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.34M | 2.97% |
Net income | -9.63M | 83.51% |
Net profit margin | — | — |
Earnings per share | -0.29 | 57.50% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.10M | -9.41% |
Total assets | 89.07M | -4.02% |
Total liabilities | 5.65M | -34.41% |
Total equity | 83.42M | — |
Shares outstanding | 24.81M | — |
Price to book | 0.59 | — |
Return on assets | -27.92% | — |
Return on capital | -29.43% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -9.63M | 83.51% |
Cash from operations | -9.13M | 3.68% |
Cash from investing | 10.08M | — |
Cash from financing | 0.00 | — |
Net change in cash | 945.00K | 109.97% |
Free cash flow | -5.29M | 10.75% |
About
Founded
2004
Headquarters
Website
Employees
20
